跳至主要内容
临床试验/CTRI/2019/03/017901
CTRI/2019/03/017901已完成未知

Micropulse laser as an adjuvant to antivascular endothelial growth factors in polypoidal choroidal vasculopathy

V Prasad Eye Institute0 个研究点目标入组 11 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
11

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients of PCV who are treatment naïve or have received intra vitreal anti- VEGF injection (at least 6 months prior to being enrolled into the study).
  • 2.Patients with best corrected visual acuity (BCVA) between 20/30 to 20/400.

排除标准

  • 1.Patients not giving consent for study
  • 2.Patients who received any form of laser treatment before enrolment into the study including: focal laser photocoagulation, vertiporfin PDT, trans pupillary thermotherapy.
  • 3.Patients who received any intravitreal injection within a period of 6 months prior to the enrolment time.
  • 4.Patients with significant cataract or corneal opacity.
  • 5.Patients having reduced vision due to any other retinal pathology.
  • 6.Patients allergic to fluorescein or Indocyanine green (ICG).
  • 7.Patients with extra macular polyps.

研究者

发起方
V Prasad Eye Institute

相似试验